Research for predictors of the efficacy of add-on therapy for overactive bladder symptoms in men treated for lower urinary tract symptoms
Not Applicable
Recruiting
- Conditions
- Benign Prostatic Hyperplasia Overactive Bladder
- Registration Number
- JPRN-UMIN000036799
- Lead Sponsor
- Department of Urology, Fukushima Medical University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Male
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
We excluded the patient had urinary tract infection, suspected urinary tract malignancy, treatment history of urinary tract malignancy and urinary tract surgery history.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The factors associated with residual overactive bladder symptoms eight weeks after the start of add-on therapy in male lower urinary tract symptoms patient
- Secondary Outcome Measures
Name Time Method